Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Cipollone and Antonio Auricchio.
Connection Strength
0.113
-
Efficacy of canakinumab in mild or severe COVID-19 pneumonia. Immun Inflamm Dis. 2021 06; 9(2):399-405.
Score: 0.058
-
Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol. 2020 Aug; 2(8):e457-ee458.
Score: 0.055
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.